# Pharmacogenomics Validation for Imatinib in Chronic Myeloid Leukemia

> **NCT01437202** · — · COMPLETED · sponsor: **Asan Medical Center** · enrollment: 100 (actual)

## Conditions studied

- Leukemia, Myelogenous, Chronic, BCR-ABL Positive

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01437202
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2012-09
- **Final completion:** 2012-10
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2014-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01437202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01437202, "Pharmacogenomics Validation for Imatinib in Chronic Myeloid Leukemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01437202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*